Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Programme

FP7
All
FP7-HEALTH (233)

Country

Albania (3)
Algeria (1)
Argentina (3)
Australia (7)
Austria (54)
Bangladesh (1)
Belgium (90)
Benin (2)
Bolivia (2)
Botswana (1)
Brazil (2)
Bulgaria (8)
Burkina Faso (6)
Cameroon (2)
Canada (7)
Chile (3)
China (3)
Colombia (2)
Croatia (3)
Cyprus (3)
Czech Republic (14)
Democratic Republic of the Congo (2)
Denmark (41)
Ecuador (2)
Egypt (5)
Estonia (10)
Ethiopia (1)
Finland (34)
France (180)
Gabon (1)
Georgia (1)
Germany (201)
Ghana (11)
Greece (20)
Guinea-Bissau (1)
Hong Kong (1)
Hungary (23)
Iceland (3)
India (16)
Indonesia (1)
Ireland (26)
Israel (40)
Italy (128)
Japan (2)
Kenya (5)
Latvia (6)
Lithuania (7)
Luxembourg (2)
Malawi (5)
Malaysia (1)
Mali (5)
Morocco (3)
Mozambique (2)
Nepal (2)
Netherlands (127)
New Zealand (1)
Nigeria (4)
Norway (28)
Peru (2)
Poland (26)
Portugal (22)
Romania (11)
Russia (6)
Senegal (4)
Singapore (1)
Slovakia (6)
Slovenia (9)
South Africa (10)
South Korea (3)
Spain (110)
Sudan (2)
Sweden (89)
Switzerland (82)
Taiwan (1)
Tanzania (8)
Thailand (1)
The Gambia (1)
Togo (1)
Tunisia (6)
Turkey (10)
Uganda (7)
United Arab Emirates (1)
United Kingdom (213)
United States (33)
Uruguay (2)
Venezuela (1)
Vietnam (1)
Zambia (1)
Zimbabwe (2)

Language

English (233)

Advanced search

Results 1 - 10 of 233
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes
ID: 258967
Start date: 2011-01-01, End date: 2018-06-30
Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signaling components. While there are several ongoing large-scale genome re-sequen...
Programme: FP7-HEALTH
Record Number: 97660
Last updated on: 2017-07-16
The European Network for Translational Research in Atrial Fibrillation
ID: 261057
Start date: 2010-11-01, End date: 2015-10-31
The initiation and perpetuation of atrial fibrillation (AF) can be regarded as a complication of a progressive transformation of the structure and functional properties of the atria. This transformation is the result of complex and multiple changes at the molecular, cellular ...
Programme: FP7-HEALTH
Record Number: 96749
Last updated on: 2017-07-12
Integrated research on DEvelopmental determinants of Aging and Longevity
ID: 259679
Start date: 2011-02-01, End date: 2016-01-31
IDEAL will obtain insight into the role of early life conditions affecting late-life health, disease and aging, and the role of epigenetic regulation therein. IDEAL will identify the determinants and targets of this epigenetic regulation utilizing a resource of unique human c...
Programme: FP7-HEALTH
Record Number: 98424
Last updated on: 2017-07-12
Metastatic tumours facilitated by hypoxic tumour micro-environments
ID: 222741
Start date: 2009-02-01, End date: 2014-07-31
Recent research suggests that the hypoxic micro-environment of tumours is one of the major drivers of metastatic spread of cancer. Furthermore, hypoxic tumour micro-environments may result in treatment resistance of cancer cells, therefore causing a double effect of reducing ...
Programme: FP7-HEALTH
Record Number: 91061
Last updated on: 2017-07-12
Vaccination against Shigella and ETEC: novel antigens, novel approaches
ID: 261472
Start date: 2010-11-01, End date: 2017-12-31
To contribute to the development of vaccines against Shigella and ETEC for children of the developing world, STOPENTERICS will provide novel solutions by imposing a two-fold paradigm switch: (i) to break the dogma of serotype-specificity by inducing a cross-protective immunit...
Programme: FP7-HEALTH
Record Number: 97173
Last updated on: 2017-07-02
The impact of Regulation (EC) No 1394/2007 on the development of Advanced Therapy Medicinal Products (ATMPs): an academic perspective
ID: 260773
Start date: 2010-09-01, End date: 2013-05-31
Advanced Therapy Medicinal Products (ATMPs) are medicinal products for human use, based on gene therapy, somatic cell therapy or tissue engineering. A rapidly growing area in translational research, they represent the ‘next generation’ of complex medicines for complex disease...
Programme: FP7-HEALTH
Record Number: 96783
Last updated on: 2017-07-02
Developing and Evaluating Communication strategies to support Informed Decisions and practice based on Evidence
ID: 258583
Start date: 2011-01-01, End date: 2015-12-31
Objective: To improve the dissemination of evidence-based recommendations by building on the work of the GRADE Working Group to develop and evaluate methods that address the targeted dissemination of guidelines. Background: Healthcare decision makers face challenges in unders...
Programme: FP7-HEALTH
Record Number: 97693
Last updated on: 2017-06-26
HEPATIC MICROFLUIDIC BIOREACTOR
[PROJECT] HEMIBIO - HEPATIC MICROFLUIDIC BIOREACTOR
ID: 266777
Start date: 2011-01-01, End date: 2015-12-31
The goal of HeMiBio is to develop a hepatic microfluidic bioreactor from human iPSC-derived hepatocytes, hepatic sinusoidal endothelial cells (HSEC) and stellate cells (HSC), suitable for inclusion in a repeated dose toxicity testing strategy of pharmaceuticals/cosmetic ingre...
Programme: FP7-HEALTH
Record Number: 105662
Last updated on: 2017-06-12
Stem Cells for Relevant Efficient Extended and Normalized Toxicology
ID: 266753
Start date: 2011-01-01, End date: 2015-12-31
In the development of products for use by humans it is vital to identify compounds with toxic properties at an early stage of their development, to avoid spending time and resource on unsuitable and potentially unsafe candidate products. Human pluripotent stem cell lines offe...
Programme: FP7-HEALTH
Record Number: 97710
Last updated on: 2017-06-12
Effective Perinatal Intensive Care in Europe: translating knowledge into evidence based practice
ID: 259882
Start date: 2011-01-01, End date: 2015-12-31
Context: Very preterm infants face high risks of mortality and long-term neuro-developmental impairment. Rates of mortality and morbidity vary by a factor greater than two between European regions. This project’s overriding aim is to improve these infants’ survival and long-t...
Programme: FP7-HEALTH
Record Number: 97698
Last updated on: 2017-06-12
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-07-22
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top